Psychotic experiences and disability: Findings from the Collaborative Psychiatric Epidemiology Surveys.


Por: Oh H, Koyanagi A, Kelleher I and DeVylder J

Publicada: 1 mar 2018 Ahead of Print: 7 ago 2017
Resumen:
Psychotic experiences are associated with a number of poor clinical outcomes, including multimorbid psychopathology, suicidal behavior, and poor treatment response. We wished to investigate the relationship between psychotic experiences and disability, including the following domains: cognition, mobility, self-care, social interaction, role functioning, and days out of role. We used three nationally representative and racially/ethnically diverse samples of the general US adult population: the National Comorbidity Survey Replication (NCS-R), the National Latino and Asian American Survey (NLAAS), and the National Survey of American Life (NSAL). Multi-variable logistic regression analyses were used to assess the associations between lifetime psychotic experiences (visual and auditory hallucinatory experiences and delusional ideation; WHO Composite International Diagnostic Interview psychosis screen) and 30-day impairments in functioning across disability domains (using the WHO Disability Assessment Schedule II). In all three samples, models were adjusted for socio-demographics and co-occurring psychiatric disorders. In the NCS-R, models were also adjusted for chronic health conditions. Across all three studies, our adjusted models showed that people with disability had anywhere from about 1.5 to over 3 times the odds of reporting lifetime psychotic experiences, depending on the domain. This was true for each disability domain, except self-care in the NLAAS and in the NSAL. Psychotic experiences are markers of risk for disability across a wide range of domains. This may explain the elevated rates of service utilization among individuals who report psychotic experiences and supports the need to assess for and respond to psychotic experiences even in the absence of psychotic disorder.

Filiaciones:
Oh H:
 University of Southern California, School of Social Work, 669 W. 34 th St., Los Angeles, CA 90089-0411, United States

Koyanagi A:
 Parc Sanitari Sant Joan de Déu, Universitat de Barcelona, Fundació Sant Joan de Déu, Dr. Antoni Pujadas, 42, Sant Boi de Llobregat, Barcelona 08830, Spain

 Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Monforte de Lemos 3-5 Pabellón 11, Madrid 28029, Spain

Kelleher I:
 Royal College of Surgeons in Ireland, Department of Psychiatry, Ardilaun House, St Stephen's Green, Dublin 2, Ireland

DeVylder J:
 Fordham University, Graduate School of Social Service, 113 W 60(th) Street, New York, NY 10023, United States
ISSN: 09209964





Schizophrenia Research
Editorial
ELSEVIER, RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, Países Bajos
Tipo de documento: Article
Volumen: 193 Número:
Páginas: 343-347
WOS Id: 000427784100053
ID de PubMed: 28797526
imagen Green Accepted

MÉTRICAS